Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.

ABSTRACT:

Purpose

To assess differences in baseline and longitudinal quality of life among Black and White individuals in the US with advanced prostate cancer.

Methods

Secondary analysis of data from the International Registry for Men with Advanced Prostate Cancer (IRONMAN) including US participants newly diagnosed with advanced prostate cancer and identifying their race as Black or White from 2017 to 2023. Participants completed the EORTC QLQ-C30 Quality of Life (QoL) Survey at study enrollment and every 3 months thereafter for up to 1 year of follow-up reporting 15 scale scores ranging from 0 to 100 (higher functioning and lower symptom scores represent better quality of life). Linear mixed effects models with race and month of questionnaire completion were fit for each scale, and m

SUBMITTER: Rencsok EM 

PROVIDER: S-EPMC10711502 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature